Riversedge Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Riversedge Advisors's LLY Position: Q3 2026 in Review
Riversedge Advisors increased its Eli Lilly (LLY) stake by 5.4% in Q3 2026, buying an estimated $74.3K and bringing the position to 1,222 shares worth $1.41M. The position accounts for 0.17% of the portfolio, ranked #55.
Riversedge Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Riversedge Advisors held 1,222 shares of Eli Lilly worth $1.41M as of Q3 2026.
- Riversedge Advisors bought 63 Eli Lilly shares in Q3 2026, an estimated $74.3K.
- Eli Lilly made up 0.17% of Riversedge Advisors's portfolio in Q3 2026, its #55 holding.
- Riversedge Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.